FULGENT GENETICS, INC. Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months
FULGENT GENETICS, INC. (FLGT) had Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months of $31.60 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Commitment and Contingencies › Recorded Unconditional Purchase Obligation, Rolling Maturity Schedule
us-gaap:RecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths · last filed 2025-02-28
- 2024-12-31: Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months $31.60M.
- 2024-09-30: Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months $30.50M.
- 2024-06-30: Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months $32.10M.
- 2024-03-31: Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months $39.60M.
| Period end | Recorded Unconditional Purchase Obligation, Due in Next Rolling Twelve Months |
|---|---|
| 2024-12-31 | $31.60M 10-K · filed 2025-02-28 |
| 2024-09-30 | $30.50M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $32.10M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $39.60M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $29.70M 10-K · filed 2024-02-28 |
| 2023-09-30 | $24.00M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $28.80M 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |